Summary
The product TEST C 250, manufactured by Unique Pharma, underwent independent testing to confirm its authenticity and potency. The sample, identified by batch number GH65732K, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Testosterone Cypionate, with a concentration of 249.28 mg/ml, closely aligning with the labeled claim of 250 mg/ml, showing a minor variance of -0.29%.
The testing process began on 14 February 2024, with the sample received on 20 February 2024, and analysis completed on 21 February 2024. While the results confirm accurate dosing, it’s important to critically evaluate reseller-submitted samples to ensure reliability. Resellers may selectively submit high-quality batches, raising questions about product consistency across the market. Independent third-party testing remains vital for comprehensive validation. This report is intended as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: TEST C 250
- Active Ingredient: Testosterone Cypionate
- Batch Number: GH65732K
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #38870
- Testing Ordered: 14 February 2024
- Sample Received: 20 February 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 250 mg/ml (as stated on the label)
- Measured Concentration: 249.28 mg/ml
- Accuracy: 99.71% (-0.29% variance from label claim)
- Variance: -0.29
Verification Details
- Verification URL: https://janoshik.com/tests/38870_3ZAFDFZYVABG
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis confirms the accuracy of the tested product but warrants scrutiny due to its submission and funding by the reseller Opitropin.EU. Resellers may selectively choose optimal batches for testing, which might not reflect overall market consistency. While Janoshik Analytical is recognized for its transparency and rigorous protocols, additional third-party testing across multiple batches would help validate the findings comprehensively.
Conclusion
The analysis indicates that TEST C 250 by Unique Pharma delivers near-perfect dosing accuracy, with a minor variance of -0.29% from the labeled concentration. This suggests a strong quality control process for this batch; however, further testing across different batches is crucial for consistent assurance. This report aims to support educational and harm reduction efforts, assisting consumers in making informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce biases; however, it still provides valuable insights when critically evaluated alongside independent third-party results. Readers are encouraged to use this information responsibly.eaders should interpret these findings critically and supplement them with independent third-party analysis.
